Annual Total Expenses
$8.23 M
-$2.82 M-25.50%
31 December 2023
Summary:
Tenax Therapeutics annual total expenses is currently $8.23 million, with the most recent change of -$2.82 million (-25.50%) on 31 December 2023. During the last 3 years, it has fallen by -$24.49 million (-74.84%). TENX annual total expenses is now -74.84% below its all-time high of $32.73 million, reached on 31 December 2021.TENX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$4.62 M
+$946.90 K+25.79%
30 September 2024
Summary:
Tenax Therapeutics quarterly total expenses is currently $4.62 million, with the most recent change of +$946.90 thousand (+25.79%) on 30 September 2024. Over the past year, it has increased by +$1.28 million (+38.25%). TENX quarterly total expenses is now -80.55% below its all-time high of $23.75 million, reached on 31 March 2021.TENX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TENX Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +38.3% |
| 3 y3 years | -74.8% | +43.8% |
| 5 y5 years | -3.8% | +64.2% |
TENX Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -74.8% | at low | at high | +273.6% |
| 5 y | 5 years | -74.8% | at low | -80.5% | +273.6% |
| alltime | all time | -74.8% | +814.9% | -80.5% | +2209.4% |
Tenax Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.62 M(+25.8%) |
| June 2024 | - | $3.67 M(-6.0%) |
| Mar 2024 | - | $3.91 M(+17.0%) |
| Dec 2023 | $8.23 M(-25.5%) | $3.34 M(+57.8%) |
| Sept 2023 | - | $2.12 M(+71.3%) |
| June 2023 | - | $1.24 M(-19.7%) |
| Mar 2023 | - | $1.54 M(-39.7%) |
| Dec 2022 | $11.05 M(-66.2%) | $2.55 M(-12.4%) |
| Sept 2022 | - | $2.92 M(+1.9%) |
| June 2022 | - | $2.86 M(+5.3%) |
| Mar 2022 | - | $2.72 M(-15.4%) |
| Dec 2021 | $32.73 M(+231.7%) | $3.21 M(-15.5%) |
| Sept 2021 | - | $3.80 M(+93.6%) |
| June 2021 | - | $1.96 M(-91.7%) |
| Mar 2021 | - | $23.75 M(+738.2%) |
| Dec 2020 | $9.87 M(+15.3%) | $2.83 M(+27.3%) |
| Sept 2020 | - | $2.23 M(+3.8%) |
| June 2020 | - | $2.14 M(-19.6%) |
| Mar 2020 | - | $2.67 M(-5.3%) |
| Dec 2019 | $8.56 M(+24.1%) | $2.81 M(+24.5%) |
| Sept 2019 | - | $2.26 M(+24.2%) |
| June 2019 | - | $1.82 M(+9.5%) |
| Mar 2019 | - | $1.66 M(-25.4%) |
| Dec 2018 | $6.89 M(-25.1%) | $2.23 M(+43.3%) |
| Sept 2018 | - | $1.55 M(-17.7%) |
| June 2018 | - | $1.89 M(+54.4%) |
| Mar 2018 | - | $1.22 M(-11.5%) |
| Dec 2017 | $9.21 M(-52.5%) | $1.38 M(+5.5%) |
| Sept 2017 | - | $1.31 M(-56.5%) |
| June 2017 | - | $3.01 M(-13.8%) |
| Mar 2017 | - | $3.50 M(-22.4%) |
| Dec 2016 | $19.39 M(+85.9%) | $4.51 M(+0.2%) |
| Sept 2016 | - | $4.50 M(-3.7%) |
| June 2016 | - | $4.67 M(-18.1%) |
| Mar 2016 | - | $5.71 M(+61.7%) |
| Dec 2015 | $10.43 M(-24.6%) | - |
| Oct 2015 | - | $3.53 M(+13.7%) |
| Sept 2015 | - | $3.10 M(-0.3%) |
| July 2015 | - | $3.11 M(-32.9%) |
| Apr 2015 | $13.83 M(-18.2%) | $4.64 M(+44.9%) |
| Mar 2015 | - | $3.20 M(+9.6%) |
| Jan 2015 | - | $2.92 M(-26.7%) |
| Oct 2014 | - | $3.98 M(+64.7%) |
| July 2014 | - | $2.42 M(-77.4%) |
| Apr 2014 | $16.90 M(+173.7%) | $10.71 M(+348.2%) |
| Jan 2014 | - | $2.39 M(+10.0%) |
| Oct 2013 | - | $2.17 M(+21.9%) |
| July 2013 | - | $1.78 M(+25.5%) |
| Apr 2013 | $6.18 M(-28.2%) | $1.42 M(-21.6%) |
| Jan 2013 | - | $1.81 M(+74.9%) |
| Oct 2012 | - | $1.04 M(-45.6%) |
| July 2012 | - | $1.91 M(-1.4%) |
| Apr 2012 | $8.61 M | $1.93 M(-4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jan 2012 | - | $2.02 M(-6.3%) |
| Oct 2011 | - | $2.16 M(-13.2%) |
| July 2011 | - | $2.49 M(-6.2%) |
| Apr 2011 | $10.58 M(+3.3%) | $2.65 M(-5.5%) |
| Jan 2011 | - | $2.81 M(+34.1%) |
| Oct 2010 | - | $2.09 M(-30.9%) |
| July 2010 | - | $3.03 M(+17.4%) |
| Apr 2010 | $10.25 M(+19.2%) | $2.58 M(-7.2%) |
| Jan 2010 | - | $2.78 M(+7.3%) |
| Oct 2009 | - | $2.59 M(+13.2%) |
| July 2009 | - | $2.29 M(+5.7%) |
| Apr 2009 | $8.60 M(+193.3%) | $2.17 M(+124.8%) |
| Jan 2009 | - | $963.50 K(-58.9%) |
| Oct 2008 | - | $2.34 M(-25.0%) |
| July 2008 | - | $3.13 M(+121.4%) |
| Apr 2008 | $2.93 M(+65.5%) | $1.41 M(+64.6%) |
| Jan 2008 | - | $858.10 K(+188.4%) |
| Oct 2007 | - | $297.50 K(-18.5%) |
| July 2007 | - | $365.00 K(-5.3%) |
| Apr 2007 | $1.77 M(-28.5%) | $385.50 K(-19.3%) |
| Jan 2007 | - | $477.70 K(+21.1%) |
| Oct 2006 | - | $394.50 K(-23.4%) |
| July 2006 | - | $514.70 K(-0.2%) |
| Apr 2006 | $2.48 M(-7.7%) | $515.80 K(-22.0%) |
| Jan 2006 | - | $660.90 K(-3.7%) |
| Oct 2005 | - | $686.10 K(+11.4%) |
| July 2005 | - | $615.80 K(-13.9%) |
| Apr 2005 | $2.68 M(+18.4%) | $715.30 K(-19.9%) |
| Jan 2005 | - | $893.30 K(+48.7%) |
| Oct 2004 | - | $600.90 K(+26.5%) |
| July 2004 | - | $475.10 K(-9.5%) |
| Apr 2004 | $2.27 M(-0.3%) | $524.70 K(-35.7%) |
| Jan 2004 | - | $815.50 K(+74.4%) |
| Oct 2003 | - | $467.60 K(+1.8%) |
| July 2003 | - | $459.40 K(+33.9%) |
| Apr 2003 | $2.27 M(-36.9%) | $343.20 K(-27.5%) |
| Jan 2003 | - | $473.60 K(-54.4%) |
| Oct 2002 | - | $1.04 M(+149.4%) |
| July 2002 | - | $416.90 K(-79.0%) |
| Apr 2002 | $3.60 M(+80.0%) | $1.99 M(+296.1%) |
| Jan 2002 | - | $501.10 K(-10.0%) |
| Oct 2001 | - | $556.70 K(-1.1%) |
| July 2001 | - | $562.90 K(-0.7%) |
| Apr 2001 | $2.00 M(+119.6%) | $566.90 K(+15.2%) |
| Jan 2001 | - | $492.00 K(-17.9%) |
| Oct 2000 | - | $599.50 K(+74.4%) |
| July 2000 | - | $343.80 K(+10.3%) |
| Apr 2000 | $911.60 K(+1.3%) | $311.60 K(+55.8%) |
| Jan 2000 | - | $200.00 K(0.0%) |
| Oct 1999 | - | $200.00 K |
| Apr 1999 | $900.00 K(-28.4%) | - |
| Apr 1998 | $1.26 M(-33.8%) | - |
| Apr 1997 | $1.90 M(-19.1%) | - |
| Apr 1996 | $2.35 M | - |
FAQ
- What is Tenax Therapeutics annual total expenses?
- What is the all time high annual total expenses for Tenax Therapeutics?
- What is Tenax Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Tenax Therapeutics?
- What is Tenax Therapeutics quarterly total expenses year-on-year change?
What is Tenax Therapeutics annual total expenses?
The current annual total expenses of TENX is $8.23 M
What is the all time high annual total expenses for Tenax Therapeutics?
Tenax Therapeutics all-time high annual total expenses is $32.73 M
What is Tenax Therapeutics quarterly total expenses?
The current quarterly total expenses of TENX is $4.62 M
What is the all time high quarterly total expenses for Tenax Therapeutics?
Tenax Therapeutics all-time high quarterly total expenses is $23.75 M
What is Tenax Therapeutics quarterly total expenses year-on-year change?
Over the past year, TENX quarterly total expenses has changed by +$1.28 M (+38.25%)